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Abstract
Background: Mammals are essentially born germ-free but the epithelial surfaces are promptly
colonized by astounding numbers of bacteria soon after birth. The most extensive microbial
community is harbored by the distal intestine. The gut microbiota outnumber ~10 times the total
number of our somatic and germ cells. The host-microbiota relationship has evolved to become
mutually beneficial. Studies in germ-free mice have shown that gut microbiota play a crucial role in
the development of the immune system. The principal aim of the present study was to elucidate
whether the presence of gut microbiota and the quality of a sterile diet containing various amounts
of bacterial contaminants, measured by lipopolysaccharide (LPS) content, can influence maturation
of the immune system in gnotobiotic mice.
Results: We have found that the presence of gut microbiota and to a lesser extent also the LPS-
rich sterile diet drive the expansion of B and T cells in Peyer's patches and mesenteric lymph nodes.
The most prominent was the expansion of CD4+ T cells including Foxp3-expressing T cells in
mesenteric lymph nodes. Further, we have observed that both the presence of gut microbiota and
the LPS-rich sterile diet influence in vitro cytokine profile of spleen cells. Both gut microbiota and
LPS-rich diet increase the production of interleukin-12 and decrease the production of interleukin-
4. In addition, the presence of gut microbiota increases the production of interleukin-10 and
interferon-γ.
Conclusion: Our data clearly show that not only live gut microbiota but also microbial
components (LPS) contained in sterile diet stimulate the development, expansion and function of
the immune system. Finally, we would like to emphasize that the composition of diet should be
regularly tested especially in all gnotobiotic models as the LPS content and other microbial
components present in the diet may significantly alter the outcome of experiments.
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The mammalian gut harbors a vast and complex micro-
bial community. The human intestinal microflora is esti-
mated to contain 500 to 1000 species and the size of the
population is ~10 times greater than the total number of
our somatic and germ cells. The role of microbiota in
many physiological processes has been demonstrated by
using animal models reared under gnotobiological condi-
tions [1-5].
Studies in germ-free (GF) animals have shown that gut
microbiota play a crucial role in the development and
maturation of the immune system [6-23]. It was demon-
strated that the gut-associated lymphoid tissue (GALT),
which is the largest immune organ, is immature in GF
mice. The content of the lamina propria CD4+ T cells, IgA
producing B cells and intraepithelial T cells is reduced in
GF animals [8-10,12,13,16,22].
Comparative experiments have also shown that the gene
expression profiles of the intestinal epithelial cells are
shaped by the presence of gut microbiota and that upreg-
ulated genes contribute to secretion of antibacterial mole-
cules at the intestinal surface and the regulation of
intestinal angiogenesis [5,15].
The effects of gut microbiota are not only limited to the
GALT but systemic immunity is also affected. GF mice
have decreased serum immunoglobulin levels and their
mesenteric lymph nodes and spleens are smaller and less
cellular [11,20,24].
A role of gut microbiota in establishing equilibrium
between TH1 and TH2 immunological responses, which is
critical to overall human and animal health, has been pos-
tulated [20,25-28]. It is not yet clear whether gut microbi-
ota and microbial components play a role in the
development and function of Tregs [29-33] which were
recently suggested to be a crucial factor in establishing
immunological homeostasis. It has been demonstrated
that cells with regulatory function are Foxp3-expressing
CD4+ T cells [34-36]. Regulatory T cells (Tregs) suppress
activation of the immune system and thereby maintain
immune system homeostasis and tolerance to self-anti-
gens and harmless exogenous antigens [34-42]. Depletion
or functional abrogation of these cells can cause inflam-
matory diseases [37-39].
Enormous amount of gut microbiota and their products
are in an intimate contact with epithelial surface of the
intestinal mucosa. Microbe-associated molecular patterns
(MAMPs) present in the intestinal content are sampled
mainly by DCs and recognized by their receptors – pattern
recognition receptors (PRRs), which include the trans-
membrane Toll-like receptors (TLRs) [43] and C-type lec-
tin receptors (CLRs) [44], and the cytoplasmic Nod-like
receptors (NLRs) [45]. The activated DCs traffic from the
intestinal epithelium and Peyer's patches into the
mesenteric lymph nodes, where they activate cells of the
adaptive immune system.
Gnotobiotic (germ-free) models represent an important
tool for unraveling the function of gut microbiota, espe-
cially their effects on the mucosal and systemic immunity.
Germ-free animals are free of live bacteria but their sterile
food contains microbial components and other immuno-
genic components. To exclude the effects of these compo-
nents a chemically defined ultrafiltered antigen-free diet
was introduced but is rarely used due to technical and
financial obstacles [6,24,46-48].
The aim of the present study was to investigate the effects
of live gut microbiota and LPS content of the sterile diet as
one of the markers of bacterial contamination on the
development of the immune system. Our preliminary
data have shown that the effect of a low LPS diet (AIN-
93G) is negligible in conventional (CV) mice. To address
the specific aims of the study we have established three
experimental groups different in terms of stimulation
with live gut microbiota and LPS: the group of GF mice fed
a low LPS diet (AIN-93G), the group of GF mice fed a LPS-
rich diet (ST1) and the fully stimulated group of CV mice
(colonized by gut microbiota and fed a LPS-rich diet).
To analyze the effects of gut microbiota and LPS content
of the sterile diet on the maturation of the immune sys-
tem, the weight, cellularity and cellular composition of
lymphoid organs were compared using the above-men-
tioned experimental groups. In addition to the immu-
nophenotypic analysis of major lymphocyte populations,
we have focused on the subpopulation of Foxp3-express-
ing T cells. The study was complemented by determining
in vitro proliferative and cytokine response of spleen cells
to LPS and concanavalin (ConA).
Results
Purified diet may have almost 100 times lower LPS content 
than a grain-based diet
We have decided to use LPS concentration as a measure of
overall bacterial contamination in diets. To study the
effect of LPS content of the sterile diet on the development
of the immune system we had to first identify the diets
with both very low and very high LPS content. The con-
centration of LPS was measured by chromogenic LAL test
and expressed in endotoxin units (EU) per μg of pellet.
The diets sorted by LPS concentration from the lowest to
the highest were AIN-93G diet (Harlan, USA), 1410 diet
(Altromin, Germany), Standard diet (Charles River, USA),
NIH-07 diet (Zeigler, USA) and ST1 diet (Velaz, Czech
Republic). In our experiments we used AIN-93G diet,Page 2 of 11
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based diet. These diets have been selected on the basis of
maximum difference in the LPS content (Fig. 1).
Gut microbiota and the LPS-rich sterile diet increase the 
weight and cellularity of lymphoid organs
We did not detect any significant difference in the weight
and cellularity of thymus isolated from CV or GF mice fed
the low LPS diet (AIN-93G) or LPS-rich diet (ST1). How-
ever, we observed a decreased weight and cellularity of
spleens from GF mice fed either diet compared to spleens
from CV mice (Fig. 2A and 2B). The peritoneal cell
number was not affected by the LPS content of the sterile
diet or by gut microbiota. In contrast, the overall MLN
and PP cell numbers increased in GF mice fed the LPS-rich
diet (ST1) compared to GF mice fed the low LPS diet
(AIN-93G) and the cell numbers further increased in the
group of CV mice (Fig. 2B).
Gut microbiota and the LPS-rich diet decreases the 
proportion of CD19+ B cells in MLNs
We found that MLNs of GF mice fed the low LPS diet
(AIN-93G) have a higher proportion of CD19+ B cells
than GF mice fed the LPS-rich diet (ST1). In addition, the
group of GF mice fed the LPS-rich diet (ST1) had a higher
proportion of CD19+ B cells in MLNs than the group of
CV mice (Fig. 3A). However, we would like to emphasize
that the presence of gut microbiota increases the absolute
numbers of CD19+ B cells in PPs, MLNs and spleen and
that the LPS-rich diet increases the absolute number in
PPs (Table 1). The observed discrepancy between the pro-
portion and total number of CD19+ B cells in MLNs is
mainly caused by the vigorous expansion of MLN CD4+ T
cells. The proportion of CD19+ B cells in Peyer's patches,
spleen and peritoneal cells remains constant irrespective
of the degree of microbial stimulation.
Gut microbiota and the LPS-rich diet stimulate the 
expansion of CD4+ T cells
To determine the role of gut microbiota and LPS content
of the diet in the development of major T cell subpopula-
tions, including Foxp3-expressing T cells, we have isolated
cells from Peyer's patches, MLNs, spleen, thymus and per-
itoneum of CV and GF mice fed either the low LPS diet
(AIN-93G) or the LPS-rich diet (ST1). The distinct cell sur-
face and intracellular markers were analyzed by flow
cytometry. We observed that the stimulating effect of LPS-
Comparison of LPS content of mouse pelleted dietsFigure 1
Comparison of LPS content of mouse pelleted diets. 
The concentration of LPS was measured to determine the 
load of microbiota-derived components in mouse diets. The 
pellets were ground, sonicated in non-pyrogenic water and 
filtered. LPS concentration in the filtrate was analyzed using 
the Chromogenic Limulus Amebocyte Lysate (LAL) Test 
(Cambrex, USA) and is expressed as endotoxin units (EU) 
per 1 μg of a diet. Results represent the mean (± SE) of four 
measurements.
The effect of gut microbiota and LPS-rich sterile diet on the weight and cell larity f lymphoid organsFigure 2
The effect of gut microbiota and LPS-rich sterile diet 
on the weight and cellularity of lymphoid organs. (A) 
Germ-free mice have smaller spleens compared to conven-
tional mice. (B) Gut microbiota and the LPS-rich diet drive 
the cellular expansion in MLNs and PPs. Results represent 
the mean (± SE) of at least 10 mice/group. Statistical analyses 
were performed using one-way analysis of variance 
(ANOVA) and a post-hoc comparison test (Tukey-Kramer). 
* indicates p < 0.05 and ** indicates p < 0.01.Page 3 of 11
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MLNs and spleen. The presence of gut microbiota further
increased the proportion of CD4+ T cells in MLNs but not
in spleen where the LPS-rich diet had already increased
the proportion of CD4+ T cells to the level found in CV
mice. The proportion of CD4+ T cells in Peyer's patches,
FACS analysis of lymphocyte subpopulations illustrates the stimulating effect of gut microbiota and LPS-rich sterile dietigure 3
FACS analysis of lymphocyte subpopulations illustrates the stimulating effect of gut microbiota and LPS-rich 
sterile diet. (A) Both gut microbiota and the LPS-rich diet decrease the proportion of CD19+ B cells in MLNs. (B) LPS-rich 
diet induces the expansion of CD4+ T cells in MLNs and spleen. (C) Microbial stimulation does not affect the proportion of 
CD8+ T cells. (D) Both gut microbiota and the LPS-rich sterile diet induce the expansion of Foxp3-expressing CD4+ T cells in 
MLNs. (E) The ratio of CD4+Foxp3- T cells to CD4+Foxp3+ T cells remains constant in all lymphoid organs. (F) Gut microbi-
ota stimulate the expansion of Foxp3-expressing CD8+ T cells in PPs and MLNs. Results represent the mean (± SE) of at least 
10 mice/group. Statistical analyses were performed using one-way analysis of variance (ANOVA) and a post-hoc comparison 
test (Tukey-Kramer). * indicates p < 0.05 and ** indicates p < 0.01.Page 4 of 11
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of the level of microbial stimulation (Fig. 3B).
Neither gut microbiota nor the LPS-rich diet affects the 
proportion of CD8+ T cells in lymphoid organs
The presence of gut microbiota has no effect on the pro-
portion of CD8+ T cells in spleen, as previously described
[48]. In addition, we show that the proportion of CD8+ T
cells is independent of gut colonization also in other lym-
phoid organs including MLNs, Peyer's patches, thymus
and peritoneal cells. In accordance with these findings we
did not observe any effect of LPS content of the diet on the
proportion of CD8+ T cells in lymphoid organs of GF
mice (Fig. 3C).
Both gut microbiota and the LPS-rich diet drive the 
expansion of Foxp3-expressing CD4+ T cells in MLNs
To investigate the effect of gut microbiota and LPS content
of the sterile diet on the development of CD4+Foxp3+ T
cells we analyzed their proportion in Peyer's patches,
MLNs, spleen, thymus and peritoneal cells in CV mice and
GF mice fed either the low LPS diet (AIN-93G) or LPS-rich
diet (ST1). We found that both gut microbiota and the
LPS-rich diet drive the expansion of CD4+Foxp3+ T cells
in MLNs (Fig. 3D). However, the proportion of
CD4+Foxp3+ T cells in other lymphoid organs was not
affected. We would like to stress that the CD4+Foxp3-/
CD4+Foxp3+ ratio remains constant in all lymphoid
organs including MLNs and is not influenced during the
Table 1: FACS analysis of lymphocyte subpopulations in conventional and germ-free Balb/c mice fed either a low LPS diet (AIN-93G) 
or a LPS-rich diet (ST1)
Number of positive lymphocytes (× 106)
Lymphoid organ/tissue Subpopulation CV ST1 GF ST1 GF AIN
Peyer's patches Total 4.69 ± 0.16 1.57 ± 0.19 0.67 ± 0.09
CD19+ 2.93 ± 0.10 1.00 ± 0.12 0.40 ± 0.05
CD3+ 1.38 ± 0.05 0.44 ± 0.05 0.21 ± 0.03
CD4+ 0.95 ± 0.03 0.33 ± 0.04 0.16 ± 0.02
CD8+ 0.27 ± 0.01 0.08 ± 0.01 0.04 ± 0.01
CD4+Foxp3+ 0.15 ± 0.01 0.04 ± 0.01 0.02 ± 0.00
CD8+Foxp3+ 0.02 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Mesenteric lymph nodes Total 17.81 ± 0.69 7.82 ± 0.57 4.96 ± 0.96
CD19+ 4.39 ± 0.17 2.96 ± 0.21 2.48 ± 0.48
CD3+ 12.10 ± 0.47 4.70 ± 0.34 2.36 ± 0.46
CD4+ 8.70 ± 0.34 3.40 ± 0.25 1.53 ± 0.30
CD8+ 2.41 ± 0.09 1.03 ± 0.07 0.64 ± 0.12
CD4+Foxp3+ 1.42 ± 0.05 0.48 ± 0.04 0.22 ± 0.04
CD8+Foxp3+ 0.06 ± 0.00 0.02 ± 0.00 0.01 ± 0.00
Spleen Total 83.14 ± 5.28 62.48 ± 3.46 66.21 ± 4.12
CD19+ 46.14 ± 2.93 35.59 ± 1.97 36.44 ± 2.27
CD3+ 24.74 ± 1.57 20.54 ± 1.14 16.93 ± 1.05
CD4+ 16.32 ± 1.04 12.35 ± 0.68 11.18 ± 0.70
CD8+ 7.00 ± 0.44 5.36 ± 0.30 5.31 ± 0.33
CD4+Foxp3+ 3.03 ± 0.19 2.16 ± 0.12 2.27 ± 0.14
CD8+Foxp3+ 0.12 ± 0.01 0.12 ± 0.01 0.11 ± 0.01
Peritoneal cells Total 2.55 ± 0.41 2.65 ± 0.06 2.50 ± 0.35
CD19+ 1.80 ± 0.29 2.22 ± 0.05 2.19 ± 0.30
CD3+ 0.11 ± 0.02 0.08 ± 0.00 0.07 ± 0.01
CD4+ 0.22 ± 0.04 0.18 ± 0.00 0.16 ± 0.02
CD8+ 0.06 ± 0.01 0.06 ± 0.00 0.05 ± 0.01
CD4+Foxp3+ 0.03 ± 0.01 0.03 ± 0.00 0.03 ± 0.00
CD8+Foxp3+ 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Thymus Total 207.03 ± 9.23 205.76 ± 8.46 205.76 ± 7.98
CD4-CD8- 8.70 ± 0.30 10.72 ± 0.50 11.87 ± 0.20
CD4+CD8+ 155.27 ± 8.13 151.59 ± 7.26 146.52 ± 7.18
CD4+CD8- 30.23 ± 1.82 28.81 ± 1.72 31.39 ± 2.39
CD8+CD4- 13.04 ± 0.67 11.93 ± 0.57 9.88 ± 0.57
CD4+Foxp3+ 1.35 ± 0.05 1.25 ± 0.03 1.15 ± 0.02
CD8+Foxp3+ 0.66 ± 0.02 0.66 ± 0.02 0.65 ± 0.01
The single cell suspensions were stained with the monoclonal antibodies as described under "Methods" and analyzed by FACS. PP and MLN cell 
numbers represent the overall cell pool isolated from one mouse. Data is a summary of at least four independent experiments (at least 10 mice/
group) and values represent the mean ± SE.Page 5 of 11
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(Fig. 3E).
Gut microbiota stimulate the expansion of Foxp3-
expressing CD8+ T cells in Peyer's patches and MLNs
We observed a stimulating effect of gut microbiota on
CD8+Foxp3+ T cells. The proportion of CD8+Foxp3+ T
cells increased in Peyer's patches and MLNs. The effect of
LPS-rich diet on the expansion of CD8+Foxp3+ T cells in
all lymphoid organs of GF mice was not significant (Fig.
3F).
In vitro proliferative response of spleen cells is not 
influenced by gut microbiota or LPS content of the sterile 
diet
Spleen cells isolated from CV mice and GF mice fed either
the low LPS diet (AIN-93G) or LPS-rich diet (ST1) were
stained with CFSE fluorescein and stimulated with conca-
navalin A (ConA). After 72 h the CFSE staining profile of
spleen cells negative for CD19 antigen (B cell marker) was
analyzed by flow cytometry. No significant difference was
found between the groups of CV and GF mice fed either
diet (Fig. 4). Thus we conclude that neither gut microbiota
nor LPS content of the sterile diet influences non-specific
proliferative response of spleen cells in vitro.
Both gut microbiota and the LPS-rich sterile diet influence 
a spleen cell cytokine profile
To characterize the effect of gut microbiota and LPS con-
tent of the sterile diet on a cytokine response, spleen cells
were stimulated with ConA and LPS. We have observed
that both gut microbiota and the LPS-rich sterile diet
influence in vitro cytokine profile of spleen cells. Both gut
microbiota and LPS-rich diet increase the production of
interleukin-12 and decrease the production of inter-
leukin-4 after ConA stimulation. In addition, the presence
of gut microbiota increases the production of interferon-γ
and an anti-inflammatory cytokine interleukin-10. We
have also found that the presence of gut microbiota
increases the production of interferon γ and interleukin-
12 in response to LPS stimulation (Fig. 5).
Discussion
LPS-driven lymphocyte expansion in PPs and MLNs of 
germ-free mice
It is generally accepted that live gut microbiota are essen-
tial for the development and maturation of the mamma-
lian immune system [10,11,14,17,18,20,21]. Multiple
studies revealed that animals kept under germ-free condi-
tions have reduced cellular components of mucosal and
systemic immunity. GF mice have decreased frequency of
DCs, CD4+ T cells, IgA producing B cells and intraepithe-
lial T cells in gut lamina propria [12,20,22,23,49]. PPs
and MLNs are smaller, less cellular (lower numbers of B
and T cells) and do not have germinal centers
[1,2,7,11,47]. Spleens of GF mice are also smaller, less cel-
lular and the proportion of CD4+ T cells is reduced [20].
Our studies confirm the important role played by gut
microbiota. In addition, we show that microbiota-derived
components present in the sterile diet stimulate the devel-
opment of the immune system even in the absence of live
gut microbiota. In the present study, we show that LPS-
rich sterile diet partially corrects the profound immuno-
logical deficiencies found in GF mice. We demonstrate
that LPS-rich diet stimulates the expansion of all major
lymphocyte subpopulations in GF MLNs and PPs, includ-
ing CD19+ B cells, CD8+ T cells and CD4+ T cells. The
proportions of CD19+ B cells, CD8+ T cells, and CD4+ T
cells in PPs of GF mice remain constant during the LPS-
driven expansion. In contrast, we observed a significant
increase in the proportion of CD4+ T cells at the expense
of CD19+ B cells in MLNs of GF mice. Our observation of
the significant increase in the proportion of CD4+ T cells
in spleen of GF mice fed LPS-rich diet is in line with recent
studies showing that monocolonization of germ-free ani-
mals with Bacteroides fragilis results in CD4+ T cell expan-
sion [20].
The effect of gut microbiota and LPS-rich diet on the 
development of Foxp3-expressing T cells
Regulatory T cells are a component of the immune system
that suppresses activation of other immune cells and thus
maintains immune system homeostasis. The latest
research suggests that Tregs are best defined by the expres-
sion of the transcription factor Foxp3 [34,35,40]. The
In vitro proliferative response of spleen cells is not influenced by gut microbiota o  LPS-rich sterile dietFigure 4
In vitro proliferative response of spleen cells is not 
influenced by gut microbiota or LPS-rich sterile diet. 
Spleen cells isolated from CV mice and GF mice fed either 
diet were stained with CFSE fluorescein and stimulated with 
ConA. After 72 h the cells were analyzed by FACS. Histo-
grams in this figure show the CFSE staining profile of lym-
phocytes negative for CD19 antigen (B cell marker). 
Proliferation was measured as the percentage of cells show-
ing decreased staining intensity of CFSE compared to the 
intensity of the CFSEbright population. Open histograms rep-
resent unstimulated control cells. The presented data are 
from a representative experiment. Each experiment was 
repeated at least three times with similar results.Page 6 of 11
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CD4+ helper T cell population and expresses high levels
of the interleukin-2 receptor alpha chain (CD25). Regula-
tory T cells comprise about 5–10% of the mature CD4+
helper T cell subpopulation in mice. Mutations in the
gene encoding Foxp3 result in the development of over-
whelming systemic autoimmunity in the first year of life
in both humans and mice.
It is still controversial whether gut microbiota and micro-
biota-derived components play a role in the development
and maturation of Tregs. In the transfer model of colitis
developing in CD4+CD45RBhigh T cell reconstituted
immune-deficient SCID mice we have shown that the
presence of normal gut microbiota enhances a functional
potency of the Treg population. The inhibitory activity of
CD4+CD45RBlow T cells from GF mice was significantly
impaired compared to the population isolated from spe-
cific-pathogen free mice [37]. It has been recently reported
that gut microbiota are crucial for the generation and
expansion of Tregs [31]. Ostman et al. reported that
CD25+ Tregs from GF mice are less effective in suppress-
ing proliferation of responder CD4+CD25- T cells. How-
ever, they did not find any difference in the proportion of
CD4+Foxp3+ T cells between CV and GF mice. The only
deficit of CD4+Foxp3+ T cells in GF mice was detected in
the liver-draining celiac lymph nodes [32]. Paradoxically,
it was reported that CD25+ Tregs from GF mice are as sup-
pressive and protective as those from CV mice [29,30] and
Min et al. recently reported that peptide antigens derived
from intestinal microorganisms are not essential for the
generation, in vivo proliferation or suppressive activity of
Tregs [33].
Gut microbiota and the LPS-rich diet influence in vitro cytokine response of spleen cellsFigure 5
Gut microbiota and the LPS-rich diet influence in vitro cytokine response of spleen cells. Spleen cells from CV and 
GF mice fed the low LPS diet (AIN-93G) or LPS-rich diet (ST1) were stimulated with ConA or LPS for 48 h. The production of 
IFNγ, IL-4, IL-10 and IL-12 cytokines was determined by Luminex analyzer. Results represent the mean (± SE) of at least 6 
mice/group. Statistical analyses were performed using one-way analysis of variance (ANOVA) and a post-hoc comparison test 
(Tukey-Kramer). * indicates p < 0.05 and ** indicates p < 0.01.Page 7 of 11
(page number not for citation purposes)
BMC Immunology 2008, 9:65 http://www.biomedcentral.com/1471-2172/9/65Our results are consistent with the results of Strauch et al.
and Ostman et al., which demonstrate the important role
of gut microbiota in the development and function of
Tregs. We show that both live gut microbiota and LPS-rich
sterile diet expand the absolute cell numbers of Foxp3-
expressing CD4+ T cells in MLNs and PPs (Table 1). In
addition, we observed that the stimulating effect of both
gut microbiota and LPS-rich sterile diet significantly
increased the proportion of CD4+Foxp3+ T cells in MLNs.
Gut microbiota and inflammatory diseases
Increase in hygienic standards associated with a lack of
undefined infectious stimuli mainly during the early post-
natal period was regarded to be responsible for increasing
prevalence of chronic inflammatory diseases in developed
countries – the so called "hygiene hypothesis" was formu-
lated [28].
Based on epidemiological studies it was suggested that the
composition of gut microbiota could affect the suscepti-
bility to the development of inflammatory diseases
including allergic and autoimmune diseases [50-52]. The
major recently proposed mechanism explaining the
"hygiene hypothesis" is that the developing immune sys-
tem must receive sufficient stimuli in order to adequately
develop Tregs, or it will be more susceptible to autoim-
mune and allergic diseases, because of insufficiently
repressed effector TH1 and TH2 responses, respectively
[52]. Our data are in line with the proposed mechanism
as we have found that both gut microbiota as well as LPS-
rich diet drive the expansion of CD4+Foxp3+ T cells in
MLNs. In addition, we observed a stimulating effect of gut
microbiota on IL-10 production.
The role of Tregs in the development of chronic inflam-
matory diseases and its relation to microbiota composi-
tion is currently the subject of our research performed in
gnotobiotic animal models.
How microbiota-derived components influence the 
maturation of the immune system
Several mechanisms by which gut microbiota and their
components may influence the development of the
immune system have been proposed. According to the
current knowledge the nature of TLR, CLR and NLR lig-
ands selectively determines the cytokine production by
DCs and thus modulates T-cell differentiation.
Gut intraluminal antigens are sampled by DCs in the
Peyer's patches and the intestinal epithelium and carried
to the MLNs via the afferent lymphatics. In the MLNs the
DCs induce T-cell activation and differentiation. The DCs
are activated through the recognition of microbial compo-
nents, such as LPS. However, other activating components
of the intestinal content including fatty acids (recognized
by TLR4 receptor) [53], beta-glucan (recognized by dec-
tin-1 receptor) [54], wheat [55] and other molecules may
be involved in the initiation of immune responses. The
activation of DCs leads to the production of cytokines and
expression of co-stimulatory molecules. The presentation
of processed antigens bound to MHC class II results in the
activation and differentiation of T cells. The cytokines
secreted by activated DCs play a critical role in T-cell dif-
ferentiation. The pivotal cytokines that control T-cell dif-
ferentiation are IFNγ and IL-12 (TH1), IL-4 (TH2) and TGF-β and IL-6 (TH17) and TGF-β (Tregs). The activated CD4+
T cells then migrate to effector tissues where they help to
orchestrate the immune responses.
MLNs serve as a bridge between innate and adaptive
immunity and are the key site for the induction of
mucosal tolerance to intestinal antigens [56]. Our data
show that the stimulating effect of gut microbiota and
microbiota-derived components is essential for the matu-
ration of CD4+ T cell subpopulations including Foxp3-
expressing T cells in MLNs.
Conclusion
In conclusion, our results demonstrate that the presence
of gut microbiota and to a lesser extent also the LPS-rich
sterile diet drive the expansion of B and T cells in Peyer's
patches and mesenteric lymph nodes. The most promi-
nent was the expansion of CD4+ T cells including Foxp3-
expressing T cells in mesenteric lymph nodes. Further, we
have observed that both the presence of gut microbiota
and the LPS-rich sterile diet influence in vitro cytokine pro-
file of spleen cells. Both gut microbiota and LPS-rich diet
increase the production of interleukin-12 and decrease
the production of interleukin-4. In addition, the presence
of gut microbiota increases the production of interleukin-
10 and interferon-γ. Finally, we would like to emphasize
that the content of microbial components in sterile diets
has a significant effect on the development and function
of the immune system under germ-free conditions and




Both germ-free (GF) and conventional (CV) Balb/c mice
were maintained on a sterile experimental diet for at least
two generations. After weaning the mice were fed a sterile
experimental diet ad libitum and used in experiments at
the age of 8–10 weeks.
Long-term colonies of germ-free Balb/c mice have been
established using the rederivation by a Caesarean section
and maintained in flexible plastic isolators. Fecal samples
from GF mice and swabs from the inner surface of the iso-
lators were cultured under both aerobic and anaerobicPage 8 of 11
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to verify continued sterility of the colony. The conven-
tional Balb/c mice were regularly checked for the absence
of potential pathogens according to an internationally
established standard (FELASA). All the experiments were
performed in the Department of Immunology and Gnoto-
biology of the Institute of Microbiology of the AS CR. All
the researchers who handled the animals have been certi-
fied by the Central Committee for Animal Welfare. The
Institute of Microbiology is authorized by the Central
Committee for Animal Welfare to carry out experiments
on laboratory animals. The local ethical guidelines are in
compliance with Directive 86/609/EEC on the protection
of animals used for experimental and other scientific pur-
poses and Recommendation 2007/526/EC of the Euro-
pean Commission.
Determination of LPS content of mouse feed pellets
We have tested all the pelleted diets which are commonly
used in our animal facility. Namely AIN-93G diet (Har-
lan, USA), 1430 diet with gluten-free modification
(Altromin, Germany), Charles River's standard diet
(Charles River, USA), rodent NIH-07 22.5–5 diet (Ziegler,
USA) and ST1 diet (Velaz, Czech Republic). To determine
the LPS content of mouse diets, the pellets were ground,
sonicated in non-pyrogenic water and filtered. LPS con-
centration in the filtrate was measured using the Chro-
mogenic Limulus Amebocyte Lysate (LAL) Test (Cambrex,
USA) and expressed as endotoxin units (EU) per 1 μg of a
diet.
Diets
Mice were fed ad libitum with either a purified diet (AIN-
93G, Harlan) or a grain-based diet (ST1, Velaz). Both diets
were sterilized by irradiation. The AIN-93G diet is a
growth diet for rodents recommended by the American
Institute of Nutrition. It is based mainly on purified ingre-
dients, such as corn starch, vitamin free casein, maltodex-
trin, sucrose, soybean oil and powdered cellulose
supplemented with mineral and vitamin mix. The ST1
diet is a grain-based diet which is based mainly on wheat,
oat, corn, wheat flour, snail clover fodder, soya pollard
and scrap cake. The detailed composition of a purified
diet (AIN-93G) and a grain-based diet (ST1) is presented
in Tables D1 and D2, respectively (Additional files 1 and
2, respectively). Both experimental diets were nutrition-
ally adequate and animal growth curves were comparable.
The AIN-93G diet has an almost 100 times lower content
of LPS than ST1 diet.
Preparation of cell suspensions
The organs were cut with scissors, squeezed with a syringe
plunger and filtered through a 70 μm cell strainer (BD Fal-
con, USA). Red blood cells in spleen cell suspensions were
lysed with ACK lysing buffer (0.15 M NH4Cl, 10 mM
KHCO3, 0.1 M Na2EDTA, pH 7.3) for 5 min at room tem-
perature. All the cells were washed twice and resuspended
in complete RPMI medium (RPMI-1640 medium con-
taining 10% fetal bovine serum (FBS), 2 mM L-glutamine,
50 μM 2-mercaptoethanol, 100 U/ml penicillin and 100
μg/ml streptomycin sulphate) or FACS buffer (PBS con-
taining 0.1% NaN3 and 0.5% FBS). To harvest resident
peritoneal cells, 10 ml complete RPMI medium per
mouse was injected into the peritoneal cavity. Collected
peritoneal lavage fluid was centrifuged and then resus-
pended in harvest medium. The cells were counted and
adjusted to appropriate cell concentration.
Flow cytometry and intracellular cytokine staining
Phenotypic analysis of cells isolated from spleen, thymus,
MLNs, PPs and peritoneal cavity was performed by flow
cytometry. The following mAb with matching isotype
controls were used: FITC-conjugated anti-mouse CD3e
(BD Pharmingen, USA), PE-conjugated anti-mouse CD19
(BD Pharmingen, USA), FITC-conjugated anti-mouse
CD4 (BD Pharmingen, USA), PE-conjugated anti-mouse
CD8a (BD Pharmingen, USA), PE-Cy5-conjugated anti-
mouse CD25 (eBioscience, USA), FITC-conjugated mouse
IgG2b, κ (BD Pharmingen, USA), FITC-conjugated rat
IgG2a, κ (eBioscience, USA), PE-conjugated rat IgG2a, κ
(eBioscience, USA), PE-conjugated mouse IgG1, κ (BD
Pharmingen, USA). Cells were resuspended in FACS
buffer to a concentration of 2 × 107/ml and pre-incubated
with 1 μg of anti-mouse CD16/CD32 (eBioscience, USA)
per million cells for 5 min on ice prior to staining. Primary
antibodies were diluted to predetermined optimal con-
centrations in 50 μl of FACS buffer and dispensed into
each well of a 96-well microtiter plate. 50 μl of cell sus-
pension was added to each well and incubated for 20 min
at 4°C in the dark. After staining, cells were washed twice
and resuspended in 100 μl FACS buffer. Intracellular
staining of mouse Foxp3 was performed using PE anti-
mouse Foxp3 Staining Set (eBioscience) according to the
manufacturer's protocol. The sample data were acquired
on a FACSCalibur flow cytometer (Becton Dickinson,
USA) and analyzed with WinMDI software (Joseph Trot-
ter).
In vitro cytokine stimulation
Spleen cells were cultured at 2 × 106/ml in a 96-well flat-
bottom culture plate in complete RPMI-1640 medium.
The cells were stimulated with 100 ng/ml LPS (Ultra-Pure
LPS, Invivogen, USA) and 1.5 μg/ml ConA (Sigma-
Aldrich, USA) and incubated in a 5% CO2 at 37°C for 48
h. Culture supernatants were collected after 48 h and
stored at -20°C until analysis. Cytokine profiles were
determined using a multiplex cytokine analyzer
(Luminex).Page 9 of 11
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Freshly isolated lymphocytes were resuspended in the
solution of carboxyfluorescein diacetate succinimidyl
ester (CFSE, 5 μM final concentration) and mixed rapidly.
After 5 min at room temperature, the cells were washed
three times with 10 volumes of PBS containing 5% FBS.
CFSE-labeled cells were stimulated with 1.5 μg/ml ConA
(Sigma-Aldrich, USA) in 96-well plates for 48 h, and then
CFSE dilution was analyzed by flow cytometry.
Multiplex cytokine determination
To determine cytokine profiles in culture supernatants we
used the Antibody Bead Kits (BioSource, USA), which are
designed to be analyzed with the Luminex® 200™ System
(Luminex Corporation, USA). The samples were stained
and analyzed according to the manufacturer's recommen-
dations. Briefly, beads of defined spectral properties con-
jugated to analyte-specific capture antibodies and samples
were pipetted into the wells of a filter bottom microplate
(Millipore, USA) and incubated for 2 h. After washing the
beads, analyte-specific biotinylated detector antibodies
were added and incubated with the beads for 1 h. After
removal of excess biotinylated detector antibodies,
streptavidin conjugated to R-Phycoerythrin was added for
30 min. After washing, the beads were analyzed with the
Luminex 200™ instrument. The concentrations of analytes
were determined by monitoring the spectral properties of
the beads and the amount of R-Phycoerythrin fluores-
cence.
Data analysis
Analysis of data was conducted using BioStat 2007 soft-
ware (AnalystSoft, Vancouver, CA). Data are expressed as
mean ± standard error (SE). Differences between groups
were examined for statistical significance using one-way
analysis of variance (ANOVA) with a post-hoc analysis
(Tukey-Kramer test). Values of p < 0.05 were regarded as
significant and are denoted in the figures. * indicates p <
0.05 and ** indicates p < 0.01.
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